IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study
· Dr. Christopher Kellner from Mount Sinai Health System successfully enrolled the first patients in the DIVE (Deployment of Irrigating Intraventricular Catheter System) study. · DIVE is designed to measure the effectiveness of IRRAflow to treat intraventricular hemorrhage versus standard EVD treatment. · The Neurosurgery and Neurology Departments at The Mount Sinai Hospital were recently ranked 9th in the US, according to U.S. News and World Report.Stockholm, August 23, 2022 – IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products